Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Willem Erkelens

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Disorders

Activities & Behaviors

Fasting

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
36
de Bruin, Tjerk
11
Twickler, Th
11
Dallinga-Thie, Geesje
9
Cabezas, Castro
9
Castro Cabezas, Manuel
9
Gispen, Willem Hendrik
8
Halkes, C J M
7
Banga, Jan-Dirk
7
Meijssen, S
7
Westerveld, Tineke
6
van Greevenbroek, Marleen
6
van Haeften, Timon
6
Koppeschaar, Hans
6
Dullaart, R P F
6
Hoekstra, J B L

Sign-in to see all Coauthors

Publications

TOP 3
Stork Alexander D M; Erkelens D Willem; Veneman Thiemo F
A practical insulin infusion algorithm for the establishment of euglycaemia in both lean and obese patients with type 1 and type 2 diabetes.
Stork Alexander D M; Kemperman Hans; Erkelens D Willem; Veneman Thiemo F
Comparison of the accuracy of the HemoCue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia.
Castro Cabezas M; Verseyden C; Meijssen S; Jansen H; Erkelens D W
Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemia.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Willem Erkelens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2006: Stork Alexander D M; Erkelens D Willem; Veneman Thiemo F
A practical insulin infusion algorithm for the establishment of euglycaemia in both lean and obese patients with type 1 and type 2 diabetes.
Diabetes research and clinical practice 2006;72(3):251-7.
2005: Stork Alexander D M; Kemperman Hans; Erkelens D Willem; Veneman Thiemo F
Comparison of the accuracy of the HemoCue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(2):275-81.
2004: Castro Cabezas M; Verseyden C; Meijssen S; Jansen H; Erkelens D W
Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemia.
The Journal of clinical endocrinology and metabolism 2004;89(12):5972-80.
2004: Twickler Th B; Cramer M J M; Senden S P; Doevendans P A; de Vries W R; Erkelens D W; Koppeschaar H P F
Acromegaly and heart failure: revisions of the growth hormone/insulin-like growth factor axis and its relation to the cardiovascular system.
Seminars in vascular medicine 2004;4(2):115-20.
2004: Van Beek André P; de Ruijter-Heijstek Florianne C; Jansen Hans; Erkelens D Willem; de Bruin Tjerk W A
Sex steroids and plasma lipoprotein levels in healthy women: The importance of androgens in the estrogen-deficient state.
Metabolism: clinical and experimental 2004;53(2):187-92.
2004: Stades A M E; Heikens J T; Erkelens D W; Holleman F; Hoekstra J B L
Metformin and lactic acidosis: cause or coincidence? A review of case reports.
Journal of internal medicine 2004;255(2):179-87.
2003: van Wijk J P H; Halkes C J M; De Jaegere P P Th; Plokker H W M; Erkelens D W; Cabezas M Castro
Normalization of daytime triglyceridemia by simvastatin in fasting normotriglyceridemic patients with premature coronary sclerosis.
Atherosclerosis 2003;171(1):109-16.
2003: Halkes C J M; van Dijk H; Verseyden C; de Jaegere P P Th; Plokker H W M; Meijssen S; Erkelens D W; Cabezas M Castro
Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(10):1875-80.
2003: Twickler T B; Bruckert E; Cramer M J M; Erkelens D W; Koppeschaar H P F
[The growth hormone/insulin-like growth factor axis. What is its role in the atherosclerotic process?]
Presse médicale (Paris, France : 1983) 2003;32(26):1238-43.
2003: van Wijk J P H; Halkes C J M; Erkelens D W; Castro Cabezas M
Fasting and daylong triglycerides in obesity with and without type 2 diabetes.
Metabolism: clinical and experimental 2003;52(8):1043-9.
2003: Twickler T B; Cramer M J M; Dallinga-Thie G M; Chapman M J; Erkelens D W; Koppeschaar H P F
Adult-onset growth hormone deficiency: Relation of postprandial dyslipidemia to premature atherosclerosis.
The Journal of clinical endocrinology and metabolism 2003;88(6):2479-88.
2003: van Venrooij Francine V; Stolk Ronald P; Banga Jan-Dirk; Sijmonsma Tjeerd P; van Tol Arie; Erkelens D Willem; Dallinga-Thie Geesje M;
Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.
Diabetes care 2003;26(4):1216-23.
2003: Twickler T B; Dallinga-Thie G M; Visseren F L J; de Vries W R; Erkelens D W; Koppeschaar H P F
Induction of postprandial inflammatory response in adult onset growth hormone deficiency is related to plasma remnant-like particle-cholesterol concentration.
The Journal of clinical endocrinology and metabolism 2003;88(3):1228-33.
2002: Meijssen S; van Dijk H; Verseyden C; Erkelens D W; Cabezas M Castro
Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(5):811-6.
2002: van Venrooij F V; Stolk R P; Banga J D; Erkelens D W; Grobbee D E
Primary and secondary prevention in cardiovascular disease: an old-fashioned concept?
Journal of internal medicine 2002;251(4):301-6.
2002: Meijssen S; Derksen R J; Bilecen S; Erkelens D W; Cabezas M Castro
In vivo modulation of plasma free fatty acids in patients with familial combined hyperlipidemia using lipid-lowering medication.
The Journal of clinical endocrinology and metabolism 2002;87(4):1576-80.
2002: Stades Aline M E; Hoekstra Joost B L; van den Tweel Ingeborg; Erkelens D Willem; Holleman Frits;
Additional lunchtime basal insulin during insulin lispro intensive therapy in a randomized, multicenter, crossover study in adults : a real-life design.
Diabetes care 2002;25(4):712-7.
2002: Roeters van Lennep Jeanine E; Westerveld H Tineke; Erkelens D Willem; van der Wall Ernst E
Risk factors for coronary heart disease: implications of gender.
Cardiovascular research 2002;53(3):538-49.
2002: Castro Cabezas M; Erkelens D W; van Dijk H
[Free fatty acids: mediators of insulin resistance and atherosclerosis]
Nederlands tijdschrift voor geneeskunde 2002;146(3):103-9.
2002: ter Braak Edith W M T; Appelman Alexander M M F; van der Tweel Ingeborg; Erkelens D Willem; van Haeften Timon W
The sulfonylurea glyburide induces impairment of glucagon and growth hormone responses during mild insulin-induced hypoglycemia.
Diabetes care 2002;25(1):107-12.
2001: Halkes C J; Castro Cabezas M; van Wijk J P; Erkelens D W
Gender differences in diurnal triglyceridemia in lean and overweight subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2001;25(12):1767-74.
2001: Erkelens D W
Insulin resistance syndrome and type 2 diabetes mellitus.
The American journal of cardiology 2001;88(7B):38J-42J.
2001: Halkes C J; van Dijk H; de Jaegere P P; Plokker H W; van Der Helm Y; Erkelens D W; Castro Cabezas M
Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(9):1526-30.
2001: Meijssen S; Cabezas M C; Ballieux C G; Derksen R J; Bilecen S; Erkelens D W
Insulin mediated inhibition of hormone sensitive lipase activity in vivo in relation to endogenous catecholamines in healthy subjects.
The Journal of clinical endocrinology and metabolism 2001;86(9):4193-7.
2001: van Wijk J P; Cabezas M C; Halkes C J; Erkelens D W
Effects of different nutrient intakes on daytime triacylglycerolemia in healthy, normolipemic, free-living men.
The American journal of clinical nutrition 2001;74(2):171-8.
2001: Twickler T B; Dallinga-Thie G M; Zelissen P M; Koppeschaar H P; Erkelens D W
The atherogenic plasma remnant-like particle cholesterol concentration is increased in the fasting and postprandial state in active acromegalic patients.
Clinical endocrinology 2001;55(1):69-75.
2001: Schreuder P C; Twickler T B; Wang T; Nakajima K; Erkelens D W; Dallinga-Thie G M
Isolation of remnant particles by immunoseparation: a new approach for investigation of postprandial lipoprotein metabolism in normolipidemic subjects.
Atherosclerosis 2001;157(1):145-50.
2001: Wilmink H W; Twickler M B; Banga J D; Dallinga-Thie G M; Eeltink H; Erkelens D W; Rabelink T J; Stroes E S
Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles.
Cardiovascular research 2001;50(3):577-82.
2001: Niemeijer-Kanters S D; Banga J D; Erkelens D W
Lipid-lowering therapy in diabetes mellitus.
The Netherlands journal of medicine 2001;58(5):214-22.
2001: Niemeijer-Kanters S D; Dallinga-Thie G M; de Ruijter-Heijstek F C; Algra A; Erkelens D W; Banga J D; Jansen H
Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus.
Atherosclerosis 2001;156(1):209-16.
2001: Castro Cabezas M; Halkes C J; Erkelens D W
Obesity and free fatty acids: double trouble.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2001;11(2):134-42.
2001: Niemeijer-Kanters S D; Banga J D; Erkelens D W
[Dyslipidemia in diabetes mellitus]
Nederlands tijdschrift voor geneeskunde 2001;145(16):769-74.
2001: Castro Cabezas M; Halkes C J; Meijssen S; van Oostrom A J; Erkelens D W
Diurnal triglyceride profiles: a novel approach to study triglyceride changes.
Atherosclerosis 2001;155(1):219-28.
2000: Twickler T B; Wilmink H W; Schreuder P C; Cabezas M C; van Dam P S; Koppeschaar H P; Erkelens D W; Dallinga-Thie G M
Growth hormone (GH) treatment decreases postprandial remnant-like particle cholesterol concentration and improves endothelial function in adult-onset GH deficiency.
The Journal of clinical endocrinology and metabolism 2000;85(12):4683-9.
2000: van Oostrom A J; Castro Cabezas M; Ribalta J; Masana L; Twickler T B; Remijnse T A; Erkelens D W
Diurnal triglyceride profiles in healthy normolipidemic male subjects are associated to insulin sensitivity, body composition and diet.
European journal of clinical investigation 2000;30(11):964-71.
2000: Twickler T B; Dallinga-Thie G M; de Valk H W; Schreuder P C; Jansen H; Cabezas M C; Erkelens D W
High dose of simvastatin normalizes postprandial remnant-like particle response in patients with heterozygous familial hypercholesterolemia.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(11):2422-7.
2000: van Lennep J E; Westerveld H T; van Lennep H W; Zwinderman A H; Erkelens D W; van der Wall E E
Apolipoprotein concentrations during treatment and recurrent coronary artery disease events.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(11):2408-13.
2000: ter Braak E W; Appelman A M; van de Laak M; Stolk R P; van Haeften T W; Erkelens D W
Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia.
Diabetes care 2000;23(10):1467-71.
2000: Visseren F L; Bouwman J J; Bouter K P; Diepersloot R J; de Groot P H; Erkelens D W
Procoagulant activity of endothelial cells after infection with respiratory viruses.
Thrombosis and haemostasis 2000;84(2):319-24.
2000: ter Braak E W; de Valk H W; de la Bije Y F; van der Laak M F; van Haeften T W; Erkelens D W
Response to training in blood glucose awareness is related to absence of previous hypoglycemic coma.
Diabetes care 2000;23(8):1199-200.
2000: Zonderland M L; Dubbeldam S; Erkelens D W; van Haeften T W
Lower beta-cell secretion in physically active first-degree relatives of type 2 diabetes patients.
Metabolism: clinical and experimental 2000;49(7):833-8.
2000: Meijssen S; Cabezas M C; Twickler T B; Jansen H; Erkelens D W
In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia.
Journal of lipid research 2000;41(7):1096-102.
2000: Hart L M; Dekker J M; van Haeften T W; Ruige J B; Stehouwer C D; Erkelens D W; Heine R J; Maassen J A
Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus.
Diabetologia 2000;43(4):515-9.
2000: Cabezas M C; Erkelens D W
Triglycerides and atherosclerosis: to feast or fast.
The Netherlands journal of medicine 2000;56(3):110-8.
2000: van Greevenbroek M M; Erkelens D W; de Bruin T W
Caco-2 cells secrete two independent classes of lipoproteins with distinct density: effect of the ratio of unsaturated to saturated fatty acid.
Atherosclerosis 2000;149(1):25-31.
2000: Visseren F L; Lansberg P J; Erkelens D W; Kastelein J J
[Statins: possibly more than just lowering of the lipid level]
Nederlands tijdschrift voor geneeskunde 2000;144(7):316-21.
2000: van de Laak M F; ter Braak E W; Erkelens D W
[Diabetic ketoacidosis presenting as acute abdomen]
Nederlands tijdschrift voor geneeskunde 2000;144(4):153-6.
1999: Erkelens D W
Internal medicine in the 21st century, from skill to approach.
The Netherlands journal of medicine 1999;55(6):254-6.
1999: Smit J W; De Bruin T W; Eekhoff E M; Glatz J; Erkelens D W
Combined hyperlipidemia is associated with increased exercise-induced muscle protein release which is improved by triglyceride-lowering intervention.
Metabolism: clinical and experimental 1999;48(12):1518-23.
1999: van Beek A P; de Ruijter-Heijstek F C; Erkelens D W; de Bruin T W
Menopause is associated with reduced protection from postprandial lipemia.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(11):2737-41.
1999: van Oostrom A J; Castro Cabezas M; Harmelink M J; Twickler T B; Remijnse T A; Erkelens D W
[Diurnal triglyceride profiles in 30 young healthy men as a function of diet, fasting triglyceride levels, body composition and insulin sensitivity]
Nederlands tijdschrift voor geneeskunde 1999;143(37):1868-72.
1999: Erkelens D W
[The 'Diabetes mellitus type 2' guideline (first revision) of the Dutch College of General Practitioners: response from internal medicine]
Nederlands tijdschrift voor geneeskunde 1999;143(33):1686-8.
1999: Ligtenberg P C; Blans M; Hoekstra J B; van der Tweel I; Erkelens D W
No effect of long-term physical activity on the glycemic control in type 1 diabetes patients: a cross-sectional study.
The Netherlands journal of medicine 1999;55(2):59-63.
1999: Kanters S D; Algra A; de Bruint T W; Erkelens D W; Banga J D
Intensive lipid-lowering strategy in patients with diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1999;16(6):500-8.
1999: de Valk H W; Hardus P L; van Rijn H J; Erkelens D W
Plasma magnesium concentration and progression of retinopathy.
Diabetes care 1999;22(5):864-5.
1999: Visseren F L; Erkelens D W
[Atherosclerosis as an infectious disease]
Nederlands tijdschrift voor geneeskunde 1999;143(6):291-5.
1999: Ligtenberg P C; Hoekstra J B; Frölich M; Meinders A E; Erkelens D W
Serum leptin levels are not influenced by physical training in type 2 diabetes mellitus patients.
Diabetes, obesity & metabolism 1999;1(1):23-7.
1998: Cabezas M C; de Bruin T W; Westerveld H E; Meijer E; Erkelens D W
Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia.
Journal of internal medicine 1998;244(4):299-307.
1998: van Greevenbroek M M; Robertus-Teunissen M G; Erkelens D W; de Bruin T W
Lipoprotein secretion by intestinal Caco-2 cells is affected differently by trans and cis unsaturated fatty acids: effect of carbon chain length and position of the double bond.
The American journal of clinical nutrition 1998;68(3):561-7.
1998: Westerveld H T; van Lennep J E; van Lennep H W; Liem A H; de Boo J A; van der Schouw Y T; Erkelens D W
Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(7):1101-7.
1998: Castro Cabezas M; Erkelens D W
The direct way from gut to vessel wall: atheroinitiation.
European journal of clinical investigation 1998;28(6):504-5.
1998: de Valk H W; Bianchi R; van Rijn H J; Erkelens D W
Acute exogenous elevation of plasma free fatty acids does not influence the plasma magnesium concentration.
Clinical chemistry and laboratory medicine : CCLM / FESCC 1998;36(2):115-7.
1998: van Haeften T W; Dubbeldam S; Zonderland M L; Erkelens D W
Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
Diabetes care 1998;21(2):278-82.
1998: van Beek A P; van Barlingen H H; de Ruijter-Heijstek F C; Jansen H; Erkelens D W; Dallinga-Thie G M; de Bruin T W
Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity.
Journal of lipid research 1998;39(2):322-32.
1998: van Greevenbroek M M; Robertus-Teunissen M G; Erkelens D W; de Bruin T W
Participation of the microsomal triglyceride transfer protein in lipoprotein assembly in Caco-2 cells: interaction with saturated and unsaturated dietary fatty acids.
Journal of lipid research 1998;39(1):173-85.
1997: Ligtenberg P C; Hoekstra J B; Bol E; Zonderland M L; Erkelens D W
Effects of physical training on metabolic control in elderly type 2 diabetes mellitus patients.
Clinical science (London, England : 1979) 1997;93(2):127-35.
1997: van Barlingen H H; van Beek A; Erkelens D W; de Bruin T W
Danaparoid: an antithrombotic agent without major impact on triglyceride hydrolysis capacity in humans.
Journal of internal medicine 1997;242(2):125-9.
1997: van Barlingen H H; Kleinveld H A; Erkelens D W; de Bruin T W
Lipoprotein lipase-enhanced binding of lipoprotein(a) [Lp(a)] to heparan sulfate is improved by apolipoprotein E (apoE) saturation: secretion-capture process of apoE is a possible route for the catabolism of Lp(a).
Metabolism: clinical and experimental 1997;46(6):650-5.
1997: Veneman T F; Erkelens D W
Clinical review 88: hypoglycemia unawareness in noninsulin-dependent diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1997;82(6):1682-4.
1997: Erkelens D W
[Taking the temperature]
Nederlands tijdschrift voor geneeskunde 1997;141(19):924-5.
1997: Visseren F L; Bouter K P; Pon M J; Hoekstra J B; Erkelens D W; Diepersloot R J
Patients with diabetes mellitus and atherosclerosis; a role for cytomegalovirus?
Diabetes research and clinical practice 1997;36(1):49-55.
1997: Westerveld H T; Meyer E; de Bruin T W; Erkelens D W
Oestrogens and postprandial lipid metabolism.
Biochemical Society transactions 1997;25(1):45-9.
1996: de Bruin T W; Dallinga-Thie G M; Erkelens D W
[Familial combined hyperlipidemia]
Nederlands tijdschrift voor geneeskunde 1996;140(43):2118-21.
1996: Biessels G J; Kamal A; Ramakers G M; Urban I J; Spruijt B M; Erkelens D W; Gispen W H
Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats.
Diabetes 1996;45(9):1259-66.
1996: Meyer E; Westerveld H T; de Ruyter-Meijstek F C; van Greevenbroek M M; Rienks R; van Rijn H J; Erkelens D W; de Bruin T W
Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study.
Atherosclerosis 1996;124(2):221-35.
1996: Westerveld H T; Meijer E; Erkelens D W; de Bruin T W
Postprandial reduction in high-density lipoprotein cholesterol concentrations in postmenopausal women: improvement by 17beta-estradiol.
Metabolism: clinical and experimental 1996;45(7):827-32.
1996: van Barlingen H H; de Jong H; Erkelens D W; de Bruin T W
Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: modulation by apolipoprotein E and apolipoprotein C.
Journal of lipid research 1996;37(4):754-63.
1996: van Barlingen H H; Kock L A; de Man F H; Erkelens D W; de Bruin T W
In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
Atherosclerosis 1996;121(1):75-84.
1996: van Greevenbroek M M; van Meer G; Erkelens D W; de Bruin T W
Effects of saturated, mono-, and polyunsaturated fatty acids on the secretion of apo B containing lipoproteins by Caco-2 cells.
Atherosclerosis 1996;121(1):139-50.
1996: De Man F H; Cabezas M C; Van Barlingen H H; Erkelens D W; de Bruin T W
Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis.
European journal of clinical investigation 1996;26(2):89-108.
1995: Smit J W; Van Erpecum K J; Portincasa P; Renooij W; Erkelens D W; Van Berge-Henegouwen G P
Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
Gut 1995;37(5):654-9.
1995: Van Dam P S; Van Asbeck B S; Erkelens D W; Marx J J; Gispen W H; Bravenboer B
The role of oxidative stress in neuropathy and other diabetic complications.
Diabetes/metabolism reviews 1995;11(3):181-92.
1995: Smit J W; Wijnne H J; Schobben F; Sitsen A; de Bruin T W; Erkelens D W
Effects of alcohol consumption on pharmacokinetics, efficacy, and safety of fluvastatin.
The American journal of cardiology 1995;76(2):89A-96A.
1995: Smit J W; Jansen G H; de Bruin T W; Erkelens D W
Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage.
The American journal of cardiology 1995;76(2):126A-128A.
1995: Smit J W; Wijnne H J; Schobben F; Sitsen A; De Bruin T W; Erkelens D W
Effects of alcohol and fluvastatin on lipid metabolism and hepatic function.
Annals of internal medicine 1995;122(9):678-80.
1995: Contermans J; Smit J W; Bär P R; Erkelens D W
A comparison of the effects of simvastatin and pravastatin monotherapy on muscle histology and permeability in hypercholesterolaemic patients.
British journal of clinical pharmacology 1995;39(2):135-41.
1995: Smit J W; Bär P R; Geerdink R A; Erkelens D W
Heterozygous familial hypercholesterolaemia is associated with pathological exercise-induced leakage of muscle proteins, which is not aggravated by simvastatin therapy.
European journal of clinical investigation 1995;25(2):79-84.
1995: Westerveld H T; Kock L A; van Rijn H J; Erkelens D W; de Bruin T W
17 beta-Estradiol improves postprandial lipid metabolism in postmenopausal women.
The Journal of clinical endocrinology and metabolism 1995;80(1):249-53.
1995: van Greevenbroek M M; Voorhout W F; Erkelens D W; van Meer G; de Bruin T W
Palmitic acid and linoleic acid metabolism in Caco-2 cells: different triglyceride synthesis and lipoprotein secretion.
Journal of lipid research 1995;36(1):13-24.
1994: Castro Cabezas M; Erkelens D W; Kock L A; De Bruin T W
Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.
European journal of clinical investigation 1994;24(10):669-78.
1994: Biessels G J; Kappelle A C; Bravenboer B; Erkelens D W; Gispen W H
Cerebral function in diabetes mellitus.
Diabetologia 1994;37(7):643-50.
1994: Bravenboer B; Hendrikse P H; Oey P L; van Huffelen A C; Groenhout C; Gispen W H; Erkelens D W
Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4-9 analogue ORG 2766 in IDDM patients with neuropathy.
Diabetologia 1994;37(4):408-13.
1994: Reitsma J B; Castro Cabezas M; de Bruin T W; Erkelens D W
Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor.
Metabolism: clinical and experimental 1994;43(3):293-8.
1994: van der Wel A M; Castro Cabezas M; de Bruin T W; Erkelens D W
[Triglycerides and atherosclerosis; treatment of hypertriglyceridemia]
Nederlands tijdschrift voor geneeskunde 1994;138(9):448-53.
1993: Erkelens D W; de Bruin T W; Castro Cabezas M
Tulp syndrome.
Lancet 1993;342(8886-8887):1536-7.
1993: Bianchi R; Bongers V; Bravenboer B; Erkelens D W
Benfluorex decreases insulin resistance and improves lipid profiles in obese type 2 diabetic patients.
Diabetes/metabolism reviews 1993;9 Suppl 1():29S-34S.
1993: Kappelle A C; Biessels G J; Van Buren T; Erkelens D W; De Wildt D J; Gispen W H
Effects of nimodipine on sciatic nerve blood flow and vasa nervorum responsiveness in the diabetic rat.
European journal of pharmacology 1993;250(1):43-9.
1993: de Bruin T W; Brouwer C B; van Linde-Sibenius Trip M; Jansen H; Erkelens D W
Different postprandial metabolism of olive oil and soybean oil: a possible mechanism of the high-density lipoprotein conserving effect of olive oil.
The American journal of clinical nutrition 1993;58(4):477-83.
1993: Bravenboer B; Hendriksen P H; Oey L P; Gispen W H; van Huffelen A C; Erkelens D W
Is the corrected QT interval a reliable indicator of the severity of diabetic autonomic neuropathy?
Diabetes care 1993;16(9):1249-53.
1993: Zweers E J; Erkelens D W
[A Dutch family with familial Mediterranean fever]
Nederlands tijdschrift voor geneeskunde 1993;137(31):1570-3.
1993: Castro Cabezas M; de Bruin T W; Van Linde-Sibenius Trip M; Kock L A; Jansen H; Erkelens D W
Lipoprotein(a) plasma concentrations associated with lipolytic activities in eight kindreds with familial combined hyperlipidemia and normolipidemic subjects.
Metabolism: clinical and experimental 1993;42(6):756-61.
1993: Cabezas M C; de Bruin T W; Jansen H; Kock L A; Kortlandt W; Erkelens D W
Impaired chylomicron remnant clearance in familial combined hyperlipidemia.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(6):804-14.
1993: van Jaarsveld B C; Hackeng W H; Lips C J; Erkelens D W
Plasma concentrations of islet amyloid polypeptide after glucagon administration in type 2 diabetic patients and non-diabetic subjects.
Diabetic medicine : a journal of the British Diabetic Association 1993;10(4):327-30.
1993: Erkelens D W
[Myth about the disadvantage of decreasing serum cholesterol refuted]
Nederlands tijdschrift voor geneeskunde 1993;137(19):944-8.
1993: Cabezas M C; de Bruin T W; Kock L A; Kortlandt W; Van Linde-Sibenius Trip M; Jansen H; Erkelens D W
Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.
Metabolism: clinical and experimental 1993;42(4):497-503.
1993: Lips C J; Höppener J W; Erkelens D W
[Islet amyloid polypeptide or amylin; breakthrough in the diagnosis and prevention of type II diabetes mellitus?]
Nederlands tijdschrift voor geneeskunde 1993;137(15):754-7.
1993: Bianchi R; Bongers V; Bravenboer B; Erkelens D W
Effects of benfluorex on insulin resistance and lipid metabolism in obese type II diabetic patients.
Diabetes care 1993;16(4):557-9.
1993: Brouwer C B; de Bruin T W; Jansen H; Erkelens D W
Different clearance of intravenously administered olive oil and soybean-oil emulsions: role of hepatic lipase.
The American journal of clinical nutrition 1993;57(4):533-9.
1993: Kappelle A C; Bravenboer B; van Buren T; Traber J; Erkelens D W; Gispen W H
Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.
British journal of pharmacology 1993;108(3):780-5.
1993: Cabezas M C; Van Heusden G P; de Bruin T W; Van Beckhoven J R; Kock L A; Wirtz K W; Erkelens D W
Reverse cholesterol transport: relationship between free cholesterol uptake and HDL3 in normolipidaemic and hyperlipidaemic subjects.
European journal of clinical investigation 1993;23(2):122-9.
1993: de Bruin T W; van Barlingen H; van Linde-Sibenius Trip M; van Vuurst de Vries A R; Akveld M J; Erkelens D W
Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects.
The Journal of clinical endocrinology and metabolism 1993;76(1):121-6.
1993: Bravenboer B; Kappelle A C; van Buren T; Erkelens D W; Gispen W H
ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats.
Acta diabetologica 1993;30(1):21-4.
1992: Bravenboer B; Erkelens D W; Gispen W H
Rationale for the use of the ACTH4-9 analogue ORG 2766 in the treatment of diabetic neuropathy.
The Netherlands journal of medicine 1992;41(5-6):255-8.
1992: Smit J W; van Erpecum K J; Stolk M F; Geerdink R A; Cluysenaer O J; Erkelens D W; van Berge Henegouwen G P
Successful dissolution of cholesterol gallstone during treatment with pravastatin.
Gastroenterology 1992;103(3):1068-70.
1992: Bravenboer B; Kappelle A C; Hamers F P; van Buren T; Erkelens D W; Gispen W H
Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat.
Diabetologia 1992;35(9):813-7.
1992: Langens F N; Bakker H; Erkelens D W
[Diabetic patients: no danger on the road]
Nederlands tijdschrift voor geneeskunde 1992;136(35):1712-6.
1992: Erkelens D W
[The third emancipation]
Nederlands tijdschrift voor geneeskunde 1992;136(30):1436-40.
1992: Bravenboer B; Kappelle A C; Jebbink H J; Hendriksen P H; Gispen W H; Erkelens D W
[Controversies concerning the pathogenesis and treatment of diabetic neuropathies]
Nederlands tijdschrift voor geneeskunde 1992;136(17):823-6.
1992: Castro Cabezas M; de Bruin T W; Erkelens D W
Familial combined hyperlipidaemia: 1973-1991.
The Netherlands journal of medicine 1992;40(1-2):83-95.
1991: Erkelens D W
[Revision of consensus cholesterol]
Nederlands tijdschrift voor geneeskunde 1991;135(49):2337-40.
1991: Timmer R; Koningsberger J C; Erkelens D W; Thijssen J H; Lips C J; Koppeschaar H P
No effect of the long-acting somatostatin analogue octreotide in patients with insulinoma.
The Netherlands journal of medicine 1991;38(5-6):199-203.
1991: Joles J A; Willekes-Koolschijn N; van Tol A; Geelhoed-Mieras M M; Danse L H; van Garderen E; Kortlandt W; Erkelens D W; Koomans H A
Hyperlipoproteinemia in one-year-old analbuminemic rats.
Atherosclerosis 1991;88(1):35-47.
1991: Dullaart R P; Groener J E; Dikkeschei B D; Erkelens D W; Doorenbos H
Elevated cholesteryl ester transfer protein activity in IDDM men who smoke. Possible factor for unfavorable lipoprotein profile.
Diabetes care 1991;14(4):338-41.
1991: De Bruin T W; Brouwer C B; Gimpel J A; Erkelens D W
Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism.
The American journal of physiology 1991;260(3 Pt 1):E492-8.
1991: van Jaarsveld B C; Bartelink A K; Erkelens D W
Cholesterol crystal embolisation.
The Netherlands journal of medicine 1991;38(1-2):86-92.
1990: De Bruin T W; Vos M C; Kortlandt W; Bouma B N; Erkelens D W
Proteolysis of human apolipoprotein B: effect on quantitative immunoturbidimetry.
Clinica chimica acta; international journal of clinical chemistry 1990;193(3):137-45.
1990: Dullaart R P; Hoogenberg K; Groener J E; Dikkeschei L D; Erkelens D W; Doorenbos H
The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: a possible contribution to alterations in high-density lipoproteins.
European journal of clinical investigation 1990;20(6):581-7.
1990: Zonderland M L; Erich W B; Erkelens D W; Kortlandt W; Wit J M; Huisveld I A; De Ridder C M
Plasma lipids and apoproteins, body fat distribution and body fatness in early pubertal children.
International journal of obesity 1990;14(12):1039-46.
1990: De Knijff P; Stalenhoef A F; Mol M J; Gevers Leuven J A; Smit J; Erkelens D W; Schouten J; Frants R R; Havekes L M
Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia.
Atherosclerosis 1990;83(1):89-97.
1990: Erkelens D W
Strategy for diagnosis and treatment of hyperlipidemia.
Therapeutische Umschau. Revue thérapeutique 1990;47(6):443-7.
1990: van Jaarsveld B C; Hackeng W H; Nieuwenhuis M G; Erkelens D W; Geerdink R A; Lips C J
Islet-amyloid polypeptide in human plasma.
Lancet 1990;335(8680):60.
1989: Martens L L; Rutten F F; Erkelens D W; Ascoop C A
Cost effectiveness of cholesterol-lowering therapy in The Netherlands. Simvastatin versus cholestyramine.
The American journal of medicine 1989;87(4A):54S-58S.
1989: Dullaart R P; Groener J E; van Wijk H; Sluiter W J; Erkelens D W
Alimentary lipemia-induced redistribution of cholesteryl ester between lipoproteins. Studies in normolipidemic, combined hyperlipidemic, and hypercholesterolemic men.
Arteriosclerosis (Dallas, Tex.) 1989;9(5):614-22.
1989: Erkelens D W
Apolipoproteins in lipid transport, an impressionist view.
Postgraduate medical journal 1989;65(763):275-81.
1989: Dullaart R P; Groener J E; Dikkeschei L D; Erkelens D W; Doorenbos H
Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids.
Diabetologia 1989;32(1):14-9.
1989: Erkelens D W
Apolipoproteins in lipid transport, an impressionist view.
Postgraduate medical journal 1989;65 Suppl 1():S6-12.
1988: Mol M J; Erkelens D W; Gevers Leuven J A; Schouten J A; Stalenhoef A F
Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia.
Atherosclerosis 1988;69(2-3):131-7.
1988: Erkelens D W; Baggen M G; Van Doormaal J J; Kettner M; Koningsberger J C; Mol M J
Clinical experience with simvastatin compared with cholestyramine.
Drugs 1988;36 Suppl 3():87-92.
1988: Erkelens D W; Dullaart R P
In vivo evidence for cholesterol ester and triglyceride exchange between high density lipoprotein and infused triglyceride rich particles in abetalipoproteinemia.
Advances in experimental medicine and biology 1988;243():247-53.
1987: Dullaart R P; Groener J E; Erkelens D W
Effect of the composition of very low and low density lipoproteins on the rate of cholesterylester transfer from high density lipoproteins in man, studied in vitro.
European journal of clinical investigation 1987;17(3):241-8.
1986: Mol M J; Erkelens D W; Leuven J A; Schouten J A; Stalenhoef A F
Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia.
Lancet 1986;2(8513):936-9.

Sign-in to see more